ESZOPICLONE Side Effects

6979465-7 | Arteriosclerosis, Coronary Artery Disease, Disease Progression, Electrocardiogram St Segment Depression, Electrocardiogram T Wave Amplitude Decreased, Glycosylated Haemoglobin Increased, Hyperlipidaemia, Hypertension, Low Density Lipoprotein Increased
on Aug 20, 2010 Female patient from JAPAN , 71 years of age, was diagnosed with insomnia and was treated with Eszopiclone (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, coronary artery disease (What is coronary artery disease?), disease progression, electrocardiogram st segment depression, electrocardiogram t wave amplitude decreased, glycosylated haemoglobin increased, hyperlipidaemia, hypertension, low density lipoprotein increased. Eszopiclone dosage: 2 Mg; ; Oral. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6669781-0 | Abdominal Discomfort, Abdominal Pain, Condition Aggravated, Diabetes Mellitus Inadequate Control, Type 1 Diabetes Mellitus
Patient was taking Eszopiclone (View Usage). Patient had the following side effects: abdominal discomfort, abdominal pain (What is abdominal pain?), condition aggravated, diabetes mellitus inadequate control, type 1 diabetes mellitus on Mar 19, 2010 from JAPAN Additional patient health information: Female patient , 66 years of age, weighting 127.9 lb, was diagnosed with insomnia and. Eszopiclone dosage: Oral. During the same period patient was treated with NOVORAPID (View Novorapid Review and Novorapid Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6639897-3 | Condition Aggravated, Fatigue, Major Depression
Adverse event was reported on Mar 01, 2010 by a Male patient taking Eszopiclone (View Usage) (Dosage: Oral) was diagnosed with insomnia and. Location: JAPAN , 72 years of age, weighting 133.6 lb, After Eszopiclone was administered, patient had the following side effects: condition aggravated, fatigue, major depression. During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), OMEPRAL (View Omepral Review and Omepral Label ), HARNAL (View Harnal Review and Harnal Label ), DEPAS (View Depas Review and Depas Label ), PAXIL (View Paxil Review and Paxil Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), LENDORMIN (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

6529632-1 | Condition Aggravated, Major Depression
on Dec 22, 2009 Male patient from JAPAN , 72 years of age, weighting 133.6 lb, was diagnosed with insomnia and was treated with Eszopiclone (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, major depression. Eszopiclone dosage: Oral. During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), OMEPRAL (View Omepral Review and Omepral Label ), HARNAL (View Harnal Review and Harnal Label ), DEPAS (View Depas Review and Depas Label ), PAXIL (View Paxil Review and Paxil Label ), CERCINE (View Cercine Review and Cercine Label ), LENDORMIN (View Lendormin Review and Lendormin Label ). Patient was hospitalized.


6528982-2 | Completed Suicide
on Dec 14, 2009 Male patient from JAPAN , 31 years of age, was diagnosed with insomnia, depression (What is depression?) and was treated with Eszopiclone (View Usage). Patient had the following side effects: completed suicide. Eszopiclone dosage: Oral. During the same period patient was treated with CLORAZEPATE DIPOTASSIUM (Oral) (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ), SULPIRIDE (SULPIRIDE) (Oral) (View Sulpiride (sulpiride) Review and Sulpiride (sulpiride) Label ), TOFRANIL (Oral) (View Tofranil Review and Tofranil Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), RAMOSETRON HYDROCHLORIDE (View Ramosetron Hydrochloride Review and Ramosetron Hydrochloride Label ), CEREKINON (View Cerekinon Review and Cerekinon Label ), THIATON (View Thiaton Review and Thiaton Label ), ALMARL (View Almarl Review and Almarl Label ).

6423908-4 | Intentional Overdose, Mental Status Changes
Patient was taking Eszopiclone (View Usage). After Eszopiclone was administered, patient had the following side effects: intentional overdose, mental status changes on Oct 30, 2009 from UNITED STATES Additional patient health information: Female patient , 52 years of age, weighting 168.2 lb, was diagnosed with insomnia and. Eszopiclone dosage: . Patient was hospitalized.

6380613-0 | Gastric Polyps, Hiatus Hernia, Iron Deficiency Anaemia, Loss Of Consciousness, Mallory-weiss Syndrome, Melaena, Oesophagitis Haemorrhagic, Reflux Oesophagitis
Adverse event was reported on Sep 09, 2009 by a Male patient taking Eszopiclone (View Usage) (Dosage: Oral, Oral) was diagnosed with insomnia and. Location: JAPAN , 68 years of age, Patient experienced the following unwanted or unexpected effects: gastric polyps, hiatus hernia, iron deficiency anaemia, loss of consciousness, mallory-weiss syndrome, melaena, oesophagitis haemorrhagic, reflux oesophagitis. During the same period patient was treated with SULPIRIDE (View Sulpiride Review and Sulpiride Label ), POLAPREZINC (View Polaprezinc Review and Polaprezinc Label ), GANATON (View Ganaton Review and Ganaton Label ), POLYFUL (View Polyful Review and Polyful Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), NICERGOLINE (View Nicergoline Review and Nicergoline Label ), AFLOQUALONE (View Afloqualone Review and Afloqualone Label ). Patient was hospitalized.

6344981-8 | Completed Suicide
on Aug 26, 2009 Female patient from UNITED STATES , 58 years of age, was treated with Eszopiclone (View Usage). Patient had the following side effects: completed suicide. Eszopiclone dosage: . During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

6321606-9 | Affective Disorder, Fatigue, Feeling Jittery, Insomnia
on Aug 05, 2009 Male patient from JAPAN , 72 years of age, weighting 133.6 lb, was diagnosed with insomnia and was treated with Eszopiclone (View Usage). After Eszopiclone was administered, patient had the following side effects: affective disorder, fatigue, feeling jittery, insomnia. Eszopiclone dosage: ; Oral. During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), OMEPRAL /00661201/ (View Omepral /00661201/ Review and Omepral /00661201/ Label ), HARNAL (View Harnal Review and Harnal Label ), DEPAS (View Depas Review and Depas Label ), PAXIL (View Paxil Review and Paxil Label ), CERCINE (View Cercine Review and Cercine Label ), LENDORMIN (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

6276397-7 | Completed Suicide
Patient was taking Eszopiclone (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Jul 13, 2009 from JAPAN Additional patient health information: Male patient , 31 years of age, was diagnosed with insomnia, depression (What is depression?) and. Eszopiclone dosage: Oral. During the same period patient was treated with CLORAZEPATE DIPOTASSIUM (Oral) (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ), SULPIRIDE (SULPIRIDE) (Oral) (View Sulpiride (sulpiride) Review and Sulpiride (sulpiride) Label ), TOFRANIL (Oral) (View Tofranil Review and Tofranil Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), RAMOSETRON HYDROCHLORIDE (View Ramosetron Hydrochloride Review and Ramosetron Hydrochloride Label ), CEREKINON (View Cerekinon Review and Cerekinon Label ), THIATON (View Thiaton Review and Thiaton Label ), ALMARL (View Almarl Review and Almarl Label ).